GANYMED Pharmaceuticals AG Closes EUR 65 M Financing Round
11/18/2008 6:29:42 AM
More...
|
ATS Acquires Majority Shareholding in GANYMED Pharmaceuticals AG
8/21/2008 7:07:06 AM
More...
|
Selexis SA Signs Commercial License Agreement With GANYMED Pharmaceuticals AG
7/11/2007 9:25:29 AM
More...
|
GANYMED Pharmaceuticals AG Raises Euro 33.7 Million in Series C Financing Round
4/18/2007 10:47:50 AM
More...
|
Dr. Thomas M. Rinderknecht Chairs Supervisory Board Of GANYMED Pharmaceuticals AG
10/11/2006 11:12:49 AM
More...
|
GANYMED Pharmaceuticals AG Lead Antibodies Show Excellent Efficacy And Safety In Mouse Tumor Models
4/5/2006 11:57:03 AM
More...
|
Genmab A/S (DK:GEN) Licenses Cancer Target From GANYMED Pharmaceuticals AG
10/19/2005 5:11:03 PM
More...
|
GANYMED Pharmaceuticals AG Names Rainer Wessel Ph.D. As President And CEO
10/19/2005 5:10:40 PM
More...
|
New Cooperation On Identification Of Multiple Sclerosis Pathogens Established Between GANYMED Pharmaceuticals AG And The University Of Rotterdam
10/19/2005 5:10:28 PM
More...
|
Imperial College Innovations Limited Licenses T Cell Receptor (TCR) Therapy Technology To GANYMED Pharmaceuticals AG
10/19/2005 5:09:21 PM
More...
|